Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LACTIN-V for Prevention of Recurrent UTI
NCT03151967Phase 3Completed
- Sponsor
- University of Washington
- Start
- Sep 2015
- Primary completion
- Apr 2017
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in urinary tract infection (UTI) comparing LACTIN-V with Placebo (2 arms). Primary endpoint: Urinary Tract Infection Incidence at 16 weeks. Started Sep 2015; status: completed.
02
Drugs
lactobacillus crispatus ctv-05
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03151967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03151967.